Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fuwa Pediatric Calcium Carbonate + Vitamin D3 Granules is an approved combination nutritional supplement developed and marketed by Guangdong Hongshanhu Pharmaceutical. Designed specifically for pediatric use, the formulation contains calcium carbonate (providing 300 mg of elemental calcium per sachet) and vitamin D3 (100 IU). It is indicated for the prevention and treatment of calcium and vitamin D deficiencies, as well as the prevention of rickets in children. The product works by directly supplying essential minerals for bone mineralization and utilizing vitamin D3 to enhance intestinal calcium absorption and regulate calcium-phosphorus metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fuwa Pediatric Calcium Carbonate + Vitamin D3 Granules.